Status:
COMPLETED
A Probiotic That Improve Intestinal Flora
Lead Sponsor:
Wecare Probiotics Co., Ltd.
Conditions:
Intestinal Flora
Eligibility:
All Genders
19-45 years
Phase:
NA
Brief Summary
Purpose: to verify the physiological properties of Lactobacillus rhamnosus LRa05. Bacterial count:100 billion Test Objective: to test and collect the changes of intestinal flora before and after the ...
Detailed Description
In order to validate the physiological properties of the 100 billion probiotic Lactobacillus rhamnosus LRa05 product and to gather sufficient evidence to test the changes in the intestinal flora befor...
Eligibility Criteria
Inclusion
- PSQI Pittsburgh Sleep Quality Index scale score \>6 and \<18
- ISI Insomnia Severity Index scale score \>8 and \<23
Exclusion
- People who have been diagnosed with diabetes or have high blood sugar are not recommended to participate in the test;
- people whose daily diet is too light or too oily are not recommended to participate in the test; people with special dietary structure (e.g. ketogenic diet, etc.) caused by weight loss or other reasons, such as muscle gain and fat loss, are not recommended to participate in the test;
- others with special conditions are not recommended to participate, such as those who are allergic to probiotic products;
- pregnant women, lactating women and people under 19 and over 45 years old should not experiment;
- people with unhealthy stomach and intestines are not recommended to participate in the test;
- people with low body fat and BMI \<23 are not recommended to participate in the test.
Key Trial Info
Start Date :
April 20 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 11 2022
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT06103240
Start Date
April 20 2022
End Date
June 11 2022
Last Update
October 26 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Henan University of Technology
Zhengzhou, Henan, China, 450001